Fuman micro collapsed in the afternoon, and the stock price was close to the limit

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

Unpacking China | Key Chinese Firms to Watch This Week （20/09/2026-26/09/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Beyond the Car: China’s Next Wave of Intelligent Hardware

The next chapter for intelligent vehicles is unfolding both inside and beyond the car.

Moonshot AI’s Kimi K3 Joins Amazon Bedrock as Overseas Revenue-Sharing Model Takes Shape

Amazon Web Services announced on September 18 that Kimi K3, developed by China’s Moonshot AI（月之暗面）, is available on Amazon Bedrock, expanding the model’s access to enterprise customers through AWS’s managed AI platform. On September 21, National Business Daily reported that Moonshot had confirmed an overseas cloud revenue-sharing arrangement, adding a commercial dimension to the launch. The financial terms remain undisclosed.

Maersk Confirms 26 LNG Dual-Fuel Containerships as Reports Point to Chinese Yards

A.P. Moller–Maersk（马士基）has confirmed orders for 26 containerships, each with capacity of 18,600 TEU and LNG dual-fuel propulsion, for delivery in 2029 and 2030. The Danish shipping and logistics group disclosed the orders on September 18, 2026, but did not identify the shipbuilders or contract value. Industry reports point to Chinese yards securing a substantial share of the work.